World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
126
Citations
87823
World Ranking
2880
National Ranking
292

Chris J. Packard publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Chris J. Packard sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 568 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Chris J. Packard D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Chris J. Packard sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2003 - Fellow of the Royal Society of Edinburgh

Overview

Chris J. Packard is affiliated with the Glasgow Royal Infirmary in the United Kingdom. Their research primarily focuses on the areas of biochemistry, genetics, and molecular biology, as well as medicine. Within these broad fields, subfields such as cancer research and surgery have been significant in their work.

Their published output includes research on topics related to cancer, lipids, and metabolism, alongside lipoproteins and cardiovascular health.

  • Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER (2020, UNC Libraries)

Chris J. Packard has collaborated with several frequent co-authors in their research efforts, including:

  • Eliana Polisecki
  • Hind Muallem
  • Nobuyo Maeda
  • Inga Peter
  • Michele Robertson

Their work has been published notably in venues such as UNC Libraries.

Recognition within their professional community includes the award of Fellow of the Royal Society of Edinburgh in 2003.

Best Publications

  • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

    J Shepherd;S M Cobbe;I Ford;C G Isles

  • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

    James Shepherd;Gerard J Blauw;Michael B Murphy;Edward Lem Bollen

  • Major lipids, apolipoproteins, and risk of vascular disease

    E Di Angelantonio;N Sarwar;P Perry

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

    Naveed Sattar;Allan Gaw;Olga Scherbakova;Ian Ford

  • West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials

    J Shepherd;SM Cobbe;AR Lorimer;JH McKillop

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Pravastatin and the Development of Diabetes Mellitus Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Naveed Sattar;R. Dermot G. Neely

  • C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

    Stephen Kaptoge;Emanuele Di Angelantonio;Lisa Pennells;Angela M. Wood

  • Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

    A M Wallace;A D McMahon;C J Packard;A Kelly

  • Lipoprotein-Associated Phospholipase A2 as an Independent Predictor of Coronary Heart Disease

    Chris J. Packard;Denis S. J. O'reilly;Muriel J. Caslake;Alex D. Mcmahon

  • C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study

    Dilys J. Freeman;John Norrie;Muriel J. Caslake;Allan Gaw

  • Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study

    Scott W Brouilette;Jasbir S Moore;Alex D McMahon;John R Thompson

  • SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

    Steven Hageman;Lisa Pennells

  • Overproduction of large VLDL particles is driven by increased liver fat content in man.

    Martin Adiels;M. R. Taskinen;C. Packard;M. J. Caslake

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

    CJ Packard;J Shepherd;SM Cobbe;Jane B Ford

  • Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.

    Bruce A. Griffin;Dilys J. Freeman;Graeme W. Tait;Jim Thomson

  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

    G. Eiriksdottir;T. B. Harris;L. J. Launer;V. Gudnason

Frequent Co-Authors

Ian Ford
Ian Ford University of Glasgow
Naveed Sattar
Naveed Sattar University of Glasgow
James Shepherd
James Shepherd University of Glasgow
J. Wouter Jukema
J. Wouter Jukema Leiden University Medical Center
Peter W. Macfarlane
Peter W. Macfarlane University of Glasgow
Stella Trompet
Stella Trompet Leiden University Medical Center
Stuart M. Cobbe
Stuart M. Cobbe University of Glasgow
John Danesh
John Danesh University of Cambridge
Rudi G. J. Westendorp
Rudi G. J. Westendorp University of Copenhagen
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it's important to explore related online degrees and alternative pathways in healthcare. For those interested in preventative care and wellness, a nutritionist online degree can open doors to careers in dietary planning, health education, and community outreach.

Healthcare administration is another growing field, offering leadership roles in hospitals and clinics. Prospective students should research which online healthcare administration programs have cahme accreditation? to ensure they enroll in respected, career-advancing programs. Accreditation is key for credibility and future employment.

For registered nurses ready to move forward, the flexibility of a rn to bsn online no clinicals accredited program makes it easier to balance work and studies, with options available for those who prefer to complete coursework without additional clinical hours.

Nurses aiming for the highest credentials may consider dnp online programs, which can be completed more efficiently through flexible or accelerated formats. These pathways all offer specialized skills that support dynamic healthcare careers beyond traditional medical school.

Best Scientists Citing Chris J. Packard

Trending Scientists